Country · Healthcare markets
Malaysia healthcare markets
178 reports across 5 categories, with market size and growth to 2033.
Malaysia healthcare markets178 reports across 5 categories, with market size and growth to 2033.
2023–2033 CAGR · estimates
Market size in 2023 · share of the world market
Active trials (recruiting, about to start or running)
Medtronic30 reports
Johnson & Johnson27 reports
Abbott Laboratories25 reports
Pfizer Inc.24 reports
GE Healthcare23 reports
Siemens Healthineers21 reports
Novartis AG19 reports
Philips Healthcare16 reports
Sanofi15 reports
Bayer AG15 reports
Merck & Co., Inc.15 reports
IBM Watson Health13 reports
Each market name opens its Malaysia report. To compare one market across every country, see market statistics.
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| 3D Laparoscopy Imaging Systems | $5 Mn | $10 Mn | 6.9% | 0.2% | 0 |
| 3D Printed Implants | $6 Mn | $21 Mn | 13.7% | 0.2% | 0 |
| 3D Printing in Medical Application | $4 Mn | $25 Mn | 20.5% | 0.2% | 2 |
| Artificial Intelligence (AI) in Drugs Discovery | $1 Mn | $10 Mn | 26.3% | 0.2% | 1 |
| Artificial Intelligence (AI) in Healthcare | – | – | – | – | 4 |
| Artificial Intelligence (AI) in Life Sciences | $4 Mn | $38 Mn | 26.9% | 0.2% | 3 |
| Artificial Intelligence (AI) in Medical Imaging | $1 Mn | $14 Mn | 25.4% | 0.2% | 0 |
| Artificial Intelligence (AI) in Medicine | $13 Mn | $327 Mn | 37.7% | – | 4 |
| Artificial Intelligence (AI) in Pharma | – | – | – | – | 1 |
| Artificial Intelligence (AI) in Radiology | $1 Mn | $12 Mn | 28.8% | 0.2% | 0 |
| Artificial Intelligence (AI) in Remote Patient Monitoring | $1 Mn | $21 Mn | 30.6% | 0.2% | 0 |
| Artificial Intelligence (AI) Machine Learning(ML) in Healthcare | $3 Mn | $78 Mn | 38.2% | 0.2% | 4 |
| Blockchain in Genomics | $4 Mn | $591 Mn | 38.5% | 0.2% | 0 |
| Blockchain-as-a-Service | $3 Mn | $45 Mn | 29.5% | 0.2% | 0 |
| Brain Imaging, Biomarkers and NeuroInformatics | $1 Mn | $2 Mn | 4.9% | 0.2% | 7 |
| Brain PET-MRI Systems | $1 Mn | $1 Mn | 6.7% | 0.1% | 6 |
| Clinical Alarm Management | $3 Mn | $4 Mn | 3.5% | 0.2% | 0 |
| Clinical Data Management Systems | $4 Mn | $13 Mn | 12.1% | 0.2% | 0 |
| Connected Healthcare Market | $95 Mn | $1.1 Bn | 27.3% | 0.2% | 1 |
| Decentralized Clinical Trials(DCTs) | $3 Mn | $11 Mn | 15% | 0.2% | 13 |
| Dental 3D Printing | $6 Mn | $36 Mn | 20.7% | 0.2% | 2 |
| Dental CAD/CAM | $5 Mn | $14 Mn | 10.2% | 0.2% | 0 |
| Digital Biomarkers | $7 Mn | $150 Mn | 35.7% | 0.2% | 3 |
| Digital diabetes care | $21 Mn | $123 Mn | 19.5% | 0.2% | 4 |
| Digital Pathology Systems | $2 Mn | $7 Mn | 13.9% | 0.2% | 7 |
| Digital Therapeutics | $11 Mn | $75 Mn | 21.2% | 0.2% | 23 |
| Digital Twin | $3 Mn | $25 Mn | 24.5% | 0.2% | 0 |
| Digital X-ray | $28 Mn | $50 Mn | 6% | 0.2% | 28 |
| Electronic Health Record | $58 Mn | $89 Mn | 4.4% | 0.2% | 2 |
| Healthcare Information System | $467 Mn | $2.3 Bn | 17.3% | 0.2% | 50 |
| Healthcare IT | $776 Mn | $2.5 Bn | 12.6% | 0.2% | 15 |
| Home Healthcare | $582 Mn | $1.3 Bn | 8.1% | 0.2% | 28 |
| Internet Of Things In Healthcare | $160 Mn | $783 Mn | 17.2% | 0.2% | 0 |
| IoT in Healthcare | $290 Mn | $1.4 Bn | 17.3% | 0.2% | 0 |
| Long-term Care Software | $6 Mn | $19 Mn | 12.8% | 0.2% | 3 |
| Mental Health Apps | $9 Mn | $60 Mn | 20.9% | 0.2% | 2 |
| Pathology Imaging Systems | $3 Mn | $8 Mn | 12.1% | 0.2% | 7 |
| Point of Care Diagnostics | $73 Mn | $152 Mn | 7.6% | 0.2% | 139 |
| Remote Medication Management | $6 Mn | $31 Mn | 17.2% | 0.2% | 4 |
| Remote Patient Monitoring | $3 Mn | $13 Mn | 18% | 0.2% | 3 |
| Werable Healthcare Devices | $53 Mn | $325 Mn | 20% | 0.2% | 5 |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Alopecia areata | – | – | – | – | 0 |
| Alzheimers Dignostic | $3 Mn | $7 Mn | 7.1% | 0.2% | 1 |
| Ambulance Service | $50 Mn | $102 Mn | 7.3% | 0.2% | 26 |
| Ambulatory Surgery Center | $64 Mn | $119 Mn | 6.3% | 0.2% | 85 |
| Antimicrobial Susceptibility Testing | – | – | – | – | 2 |
| Bioinformatics | $20 Mn | $77 Mn | 14.6% | 0.2% | 1 |
| Biomaterial Wound Dressing | $13 Mn | $26 Mn | 6.9% | 0.2% | 4 |
| Blood Gas and Electrolyte Analyzers | $5 Mn | $9 Mn | 6.6% | 0.2% | 1 |
| Bone Cancer Diagnostic | $2 Mn | $4 Mn | 7.6% | 0.2% | 8 |
| Brain Cancer Diagnostic | $2 Mn | $9 Mn | 13.8% | 0.2% | 1 |
| Breast Cancer Diagnostic | $7 Mn | $14 Mn | 8% | 0.2% | 28 |
| Clinical Laboratory Service | – | – | – | – | 34 |
| Dental Care Service | – | – | – | – | 6 |
| Dental Imaging | $6 Mn | $12 Mn | 8.1% | 0.2% | 5 |
| Dermatology Diagnostic | $42 Mn | $123 Mn | 11.4% | 0.2% | 25 |
| Fertility Service | $34 Mn | $62 Mn | 6.3% | 0.2% | 1 |
| Healthcare Electronic Data Interchange (EDI) | $6 Mn | $16 Mn | 9.6% | 0.2% | 0 |
| Healthcare In Vitro Diagnostic | $134 Mn | $199 Mn | 4% | 0.2% | 1 |
| Hospitals and Health Systems | $7 Bn | $12.3 Bn | 5.8% | 0.2% | 375 |
| Medical Billing | $7 Mn | $22 Mn | 11.6% | 0.2% | 0 |
| Medical Tourism | $119 Mn | $384 Mn | 12.4% | 0.2% | 0 |
| Nursing Education | $17 Mn | $37 Mn | 8.3% | 0.2% | 1 |
| Patient Support Programs (PSP) | $28 Mn | $122 Mn | 16% | 0.2% | 8 |
| Point Of Care (PoC) Molecular Diagnostic | $30 Mn | $75 Mn | 9.5% | 0.2% | 9 |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Acute Care Needleless Connectors | $1 Mn | $2 Mn | 7.7% | 0.2% | 0 |
| Advanced Bipolar Direct Energy Devices | $5 Mn | $12 Mn | 8.9% | 0.2% | 1 |
| Aesthetic Lasers and Energy Devices | $3 Mn | $8 Mn | 12.3% | 0.2% | 4 |
| Air Ambulance Life Support Solutions | $7 Mn | $18 Mn | 9.3% | 0.2% | 1 |
| Airway Management Devices | $3 Mn | $5 Mn | 5.4% | 0.2% | 9 |
| Anastomosis Devices | $5 Mn | $10 Mn | 7% | 0.2% | 3 |
| Anesthesia & Respiratory Devices | $46 Mn | $117 Mn | 9.7% | 0.2% | 5 |
| Anesthesia Monitoring Devices | $4 Mn | $14 Mn | 12.7% | 0.2% | 3 |
| Angiography Devices | $20 Mn | $38 Mn | 6.5% | 0.2% | 9 |
| Angioplasty Balloons | $7 Mn | $10 Mn | 4% | 0.2% | 4 |
| Anti-Snoring Devices | $2 Mn | $5 Mn | 9% | 0.2% | 2 |
| Apheresis Equipments | $4 Mn | $8 Mn | 6.4% | 0.2% | 0 |
| Arrhythmia Monitoring Devices | $10 Mn | $17 Mn | 5.7% | 0.2% | 1 |
| Assisted Walking Aids | $4 Mn | $6 Mn | 5.7% | 0.2% | 10 |
| Audiology Devices | $13 Mn | $24 Mn | 6.6% | 0.2% | 0 |
| Defibrillator | $29 Mn | $52 Mn | 6.1% | 0.2% | 6 |
| Dental Articulators | $1 Mn | $1 Mn | 6.6% | 0.2% | 41 |
| Dental Caries Detectors | $1 Mn | $2 Mn | 12% | 0.2% | 1 |
| Dental Diagnostic and Surgical Equipments | $19 Mn | $39 Mn | 7.3% | 0.2% | 53 |
| Dental X-Ray Equipments | $3 Mn | $6 Mn | 7.4% | 0.2% | 6 |
| Diabetes Care Devices | $69 Mn | $124 Mn | 6.1% | 0.2% | 6 |
| Digital Diabetes Management | – | – | – | – | 4 |
| Direct Energy Medical Devices | $18 Mn | $30 Mn | 5.2% | 0.2% | 7 |
| Disposable Surgical Devices | $15 Mn | $30 Mn | 7.5% | 0.2% | 82 |
| Insulin Delivery Devices | $26 Mn | $49 Mn | 6.7% | 0.2% | 2 |
| Insulin Patch Pumps | $1 Mn | $5 Mn | 12.2% | 0.2% | 0 |
| Rehabilitation Equipments | $32 Mn | $59 Mn | 6.3% | 0.2% | 4 |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Adaptogens | $13 Mn | $30 Mn | 8.7% | 0.2% | 1 |
| Amino Acid | – | – | – | – | 7 |
| Anthelmintic Drug | – | – | – | – | 0 |
| Antioxidants | – | – | – | – | 1 |
| Antipyretics OTC | – | – | – | – | 0 |
| BCAA Supplement | $2 Mn | $4 Mn | 6.9% | 0.2% | 78 |
| Beauty Supplements | $7 Mn | $16 Mn | 9.4% | 0.2% | 1 |
| Biotin Supplement | $1 Mn | $1 Mn | 5.2% | 0.2% | 0 |
| Bone & Joint Health Supplements | $19 Mn | $37 Mn | 6.6% | 0.2% | 2 |
| Calcium Supplements | $4 Mn | $7 Mn | 6.2% | 0.2% | 0 |
| Cannabidiol (CBD) Supplements | $9 Mn | $41 Mn | 17% | 0.2% | 0 |
| Cardiovascular Health Supplements | $11 Mn | $19 Mn | 5.9% | 0.2% | 1 |
| Clinical Nutrition | $46 Mn | $93 Mn | 7.3% | 0.2% | 4 |
| Coenzyme Q10 | $1 Mn | $2 Mn | 9.2% | 0.2% | 0 |
| Collagen Supplements | $4 Mn | $7 Mn | 6.3% | 0.2% | 3 |
| Creatine | $1 Mn | $2 Mn | 6.5% | 0.2% | 1 |
| Dietary Supplements | $495 Mn | $921 Mn | 6.4% | 0.2% | 34 |
| Eye Health Supplements | $5 Mn | $9 Mn | 6.4% | 0.2% | 1 |
| Functional Food | $458 Mn | $893 Mn | 6.9% | 0.2% | 17 |
| Hair Growth Supplements | $3 Mn | $6 Mn | 7.5% | 0.2% | 0 |
| Herbal Supplements | $132 Mn | $279 Mn | 7.8% | 0.2% | 3 |
| Immune Health Supplement | – | – | – | – | 7 |
| Iron Supplement | $3 Mn | $6 Mn | 6.7% | 0.2% | 2 |
| Men's Health Supplements | $29 Mn | $57 Mn | 7% | 0.2% | 0 |
| Mood and Stress Supplements | $17 Mn | $38 Mn | 8.3% | 0.2% | 0 |
| Nutritional Supplements | $619 Mn | $1.2 Bn | 7% | 0.2% | 26 |
| Omega 3 Fatty Acid | $7 Mn | $14 Mn | 7.6% | 0.2% | 5 |
| Oncology Nutrition | $3 Mn | $7 Mn | 7.5% | 0.2% | 3 |
| Osteoporosis Supplements | $5 Mn | $10 Mn | 6.7% | 0.2% | 0 |
| Over The Counter (OTC) Analgesics | $35 Mn | $50 Mn | 3.6% | 0.2% | 2 |
| Over The Counter (OTC) Antifungal | $4 Mn | $6 Mn | 4% | 0.2% | 0 |
| Over The Counter (OTC) Consumer | $243 Mn | $411 Mn | 5.4% | 0.2% | 1 |
| Over The Counter (OTC) Drugs | $286 Mn | $462 Mn | 4.9% | 0.2% | 1 |
| Over The Counter (OTC) Gastrointestinal Drugs | $9 Mn | $14 Mn | 4.1% | 0.2% | 2 |
| Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs | $23 Mn | $36 Mn | 4.3% | 0.2% | 2 |
| Over The Counter (OTC) Ophthalmic Drugs | $6 Mn | $9 Mn | 4.7% | 0.2% | 3 |
| Over The Counter (OTC) Pharmaceuticals | $286 Mn | $462 Mn | 4.9% | 0.2% | 1 |
| Over The Counter (OTC) Sleep Aid Products | $9 Mn | $13 Mn | 4.2% | 0.2% | 0 |
| Over The Counter (OTC) Vitamins and Minerals | $51 Mn | $90 Mn | 5.7% | 0.2% | 8 |
| Plant-Based Supplements | $20 Mn | $44 Mn | 8.2% | 0.2% | 1 |
| Prebiotics | $13 Mn | $40 Mn | 12% | 0.2% | 2 |
| Probiotic Supplements for Gut Health | $10 Mn | $20 Mn | 7.4% | 0.2% | 13 |
| Protein Supplement | $32 Mn | $67 Mn | 7.6% | 0.2% | 14 |
| Sports Nutrition | $84 Mn | $182 Mn | 8.1% | 0.2% | 2 |
| Vitamin B12(Cobalamin) | $1 Mn | $1 Mn | 5.7% | 0.2% | 2 |
| Vitamin D Supplements | – | – | – | – | 5 |
| Weight Management Supplement | – | – | – | – | 1 |
| Women's Health Supplements | $32 Mn | $63 Mn | 7% | 0.2% | 1 |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Abuse Deterrent Opioids | – | – | – | – | 0 |
| Alexipharmic Drugs | – | – | – | – | 0 |
| Alopecia Drugs (Hair Loss) | – | – | – | – | 0 |
| Alzheimer Drugs | $8 Mn | $16 Mn | 7% | – | 1 |
| Aminoglycosides | – | – | – | – | 12 |
| Anemia Drugs | – | – | – | – | 15 |
| Anti-Aging | $142 Mn | $315 Mn | 8.3% | 0.2% | 7 |
| Anti-Depressants Drugs | $29 Mn | $39 Mn | 2.9% | 0.2% | 7 |
| Anti-Nerve Growth Factor | – | – | – | – | 5 |
| Anti-Venom | – | – | – | – | 0 |
| Anticoagulants | – | – | – | – | 4 |
| Antithrombotic Drugs | – | – | – | – | 4 |
| Artificial Skin | $4 Mn | $7 Mn | 6% | 0.2% | 0 |
| Asthma & COPD Drugs | $80 Mn | $120 Mn | 4.2% | 0.2% | 9 |
| Atherosclerosis Drugs | – | – | – | – | 11 |
| Atopic Dermatitis Drugs | $18 Mn | $58 Mn | 12.4% | 0.2% | 3 |
| Autologous Matrix-induced Chondrogenesis | – | – | – | – | 1 |
| Axial Spondyloarthritis (axSpA) | – | – | – | – | 2 |
| Biological Safety Testing | – | – | – | – | 14 |
| Biosimilar Monoclonal Antibodies | – | – | – | – | 7 |
| Biosimilars | $59 Mn | $557 Mn | 25.1% | 0.2% | 7 |
| Blood Plasma | – | – | – | – | 120 |
| Bone Marrow Aspirate Concentrates | – | – | – | – | 0 |
| Burn Care | – | – | – | – | 0 |
| Burn Ointment | – | – | – | – | 0 |
| Cancer Supportive Care Drugs | $40 Mn | $64 Mn | 4.9% | 0.2% | 24 |
| Cannabidiol (CBD) | $36 Mn | $170 Mn | 17% | 0.2% | 0 |
| Cannabis | $55 Mn | $197 Mn | 13.7% | 0.2% | 0 |
| Cell Based Immunotherapy | $27 Mn | $215 Mn | 23.2% | 0.2% | 158 |
| Contraceptives Drugs | $41 Mn | $80 Mn | 7% | 0.2% | 0 |
| Cord Blood Banking Service | $3 Mn | $6 Mn | 6.7% | 0.2% | 8 |
| Diabetes Management | $125 Mn | $254 Mn | 7.3% | 0.2% | 30 |
| Diabetic Retinopathy Drugs | $17 Mn | $32 Mn | 6.2% | 0.2% | 1 |
| Epilepsy Drugs | $15 Mn | $22 Mn | 3.7% | 0.2% | 1 |
| Gastroesophageal Reflux Disease (GERD) Drugs | $8 Mn | $11 Mn | 2.3% | 0.2% | 0 |
| Gastrointestinal Drugs | $87 Mn | $139 Mn | 4.8% | 0.2% | 55 |
| HIV Drugs | $48 Mn | $86 Mn | 6% | 0.2% | 8 |
| Oncology/Cancer Drugs | $285 Mn | $649 Mn | 8.6% | 0.2% | 176 |
"–" means we have no size for that market here yet. Values for 2033 are projected from the 2023 size and the CAGR.
Sources: market sizes and growth: Acuitas Health Analytics research. Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide, and one trial can count in more than one market. Health figures: WHO Global Health Observatory. People and health spending: World Bank. Public figures fetched 10 Nov 2026.